Longeveron Inc.
LGVN
$0.96
$0.078.15%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/17/2026
-
SeekingAlpha
3/17/2026
-
Seeking Alpha: Transcripts
3/17/2026
-
Seeking Alpha - Healthcare
3/17/2026
-
SeekingAlpha.com: All News
3/17/2026
-
Globe Newswire
3/17/2026
-
Benzinga
3/12/2026
-
TipRanks Financial Blog
3/12/2026
-
Globe Newswire
3/11/2026
-
Globe Newswire
3/10/2026
-
Benzinga
3/10/2026
-
MarketBeat
3/10/2026
-
RTT News - Momentum Stocks
3/10/2026
-
The Fly
3/10/2026
-
Globe Newswire
3/3/2026
-
PR Newswire
3/3/2026
-
CNW Group - News Releases
2/25/2026
-
Stocktwits News Feed
2/25/2026
-
The Fly
2/25/2026
-
Globe Newswire
2/13/2026
-
TipRanks Financial Blog
2/13/2026
-
The Fly
2/13/2026
-
Globe Newswire
2/5/2026
-
TipRanks Financial Blog
2/5/2026
-
The Fly
2/5/2026
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
844 470 2550
Address
Life Science & Technology Park
Suite 520 - 1951 NW 7th Avenue
Miami, FL 33136
Suite 520 - 1951 NW 7th Avenue
Miami, FL 33136
Country
Year Founded
Business Description
Sector
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is...
more